Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Antimicrobics and infectious diseases newsletter
| Antimicrobics and infectious diseases newsletter |
| Pubbl/distr/stampa | [New York, NY], : Elsevier Science, ©1994-©2002 |
| Soggetto topico |
Anti-infective agents
Communicable diseases - Treatment Communicable diseases - Diagnosis Communicable diseases Anti-infective agents - Periodicals Communicable diseases - Periodicals Anti-Infective Agents Communicable Diseases - diagnosis Antiinfectieux - Périodiques Maladies infectieuses - Traitement Maladies infectieuses - Diagnostics Maladies infectieuses - Périodiques Antiinfectieux Maladies infectieuses |
| Soggetto genere / forma | Periodicals. |
| ISSN | 1878-5611 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-996204854503316 |
| [New York, NY], : Elsevier Science, ©1994-©2002 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Antimicrobics and infectious diseases newsletter
| Antimicrobics and infectious diseases newsletter |
| Pubbl/distr/stampa | [New York, NY], : Elsevier Science, ©1994-©2002 |
| Soggetto topico |
Anti-infective agents
Communicable diseases - Treatment Communicable diseases - Diagnosis Communicable diseases Anti-infective agents - Periodicals Communicable diseases - Periodicals Anti-Infective Agents Communicable Diseases - diagnosis Antiinfectieux - Périodiques Maladies infectieuses - Traitement Maladies infectieuses - Diagnostics Maladies infectieuses - Périodiques Antiinfectieux Maladies infectieuses |
| Soggetto genere / forma | Periodicals. |
| ISSN | 1878-5611 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910147027103321 |
| [New York, NY], : Elsevier Science, ©1994-©2002 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antiviral Drugs [[electronic resource] ] : From Basic Discovery Through Clinical Trials
| Antiviral Drugs [[electronic resource] ] : From Basic Discovery Through Clinical Trials |
| Autore | Kazmierski Wieslaw M |
| Pubbl/distr/stampa | Hoboken, : Wiley, 2011 |
| Descrizione fisica | 1 online resource (470 p.) |
| Disciplina | 615/.7924 |
| Soggetto topico |
Antiviral Agents -- therapeutic use
Antiviral agents Clinical Trials as Topic Drug Discovery Drug Evaluation Epidemiologic Studies Chemistry, Pharmaceutical Evaluation Studies as Topic Investigative Techniques Anti-Infective Agents Epidemiologic Methods Pharmacology Therapeutic Uses Health Care Evaluation Mechanisms Chemistry Biological Science Disciplines Natural Science Disciplines Quality of Health Care Public Health Pharmacologic Actions Environment and Public Health Health Care Quality, Access, and Evaluation Chemical Actions and Uses Health Care Antiviral Agents Health & Biological Sciences Pharmacy, Therapeutics, & Pharmacology |
| ISBN |
1-283-20363-4
9786613203632 0-470-92935-9 0-470-92934-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
ANTIVIRAL DRUGS; CONTENTS; CONTRIBUTORS; PREFACE; PART I HUMAN IMMUNODEFICIENCY VIRUS; 1 Discovery and Development of Atazanavir; 2 Discovery and Development of PL-100, A Novel HIV-1 Protease Inhibitor; 3 Darunavir (Prezista, TMC114): From Bench to Clinic, Improving Treatment Options for HIV-Infected Patients; 4 Discovery and Development of Tipranavir; 5 TMC278 (Rilpivirine): A Next-Generation NNRTI in Phase III Clinical Development for Treatment-Naive Patients; 6 Etravirine: From TMC125 to Intelence: A Treatment Paradigm Shift for HIV-Infected Patients
7 Discovery and Development of Tenofovir Disoproxil Fumarate8 Discovery and Development of Apricitabine; 9 Discovery and Development of Maraviroc and PF-232798: CCR5 Antagonists for the Treatment of HIV-1 Infection; 10 Discovery of the CCR5 Antagonist Vicriviroc (Sch 417690/Sch-D) for the Treatment of HIV-1 Infection; 11 Discovery and Development of HIV-1 Entry Inhibitors That Target gp120; 12 Discovery of MK-0536: A Potential Second-Generation HIV-1 Integrase Strand Transfer Inhibitor with a High Genetic Barrier to Mutation; 13 Discovery and Development of HIV Integrase Inhibitor Raltegravir 14 Elvitegravir: A Novel Monoketo Acid HIV-1 Integrase Strand Transfer InhibitorPART II HEPATITIS C VIRUS; 15 Discovery and Development of Telaprevir; 16 Discovery and Development of BILN 2061 and Follow-up BI 201335; 17 Intervention of Hepatitis C Replication Through NS3-4A, the Protease Inhibitor Boceprevir; 18 Discovery and Development of the HCV NS3/4A Protease Inhibitor Danoprevir (ITMN-191/RG7227); 19 Discovery and Development of the HCV Protease Inhibitor TMC435; 20 Discovery and Clinical Evaluation of the Nucleoside Analog Balapiravir (R1626) for the Treatment of HCV Infection 21 Discovery and Development of PSI-6130/RG712822 Discovery of Cyclophilin Inhibitor NIM811 as a Novel Therapeutic Agent for HCV; 23 HCV Viral Entry Inhibitors; PART III RESPIRATORY SYNCYTIAL VIRUS INHIBITORS; 24 Discovery of the RSV Inhibitor TMC353121; 25 Discovery and Development of Orally Active RSV Fusion Inhibitors; 26 Discovery and Development of RSV604; PART IV INFLUENZA, HEPATITIS B, AND CYTOMEGALOVIRUS INHIBITORS; 27 Discovery and Development of Influenza Virus Sialidase Inhibitor Relenza; 28 Discovery and Development of Entecavir 29 Benzimidazole Ribonucleosides: Novel Drug Candidates for the Prevention and Treatment of Cytomegalovirus DiseasesINDEX; Color Plate |
| Record Nr. | UNINA-9910139613803321 |
Kazmierski Wieslaw M
|
||
| Hoboken, : Wiley, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antiviral Drugs [[electronic resource] ] : From Basic Discovery Through Clinical Trials
| Antiviral Drugs [[electronic resource] ] : From Basic Discovery Through Clinical Trials |
| Autore | Kazmierski Wieslaw M |
| Pubbl/distr/stampa | Hoboken, : Wiley, 2011 |
| Descrizione fisica | 1 online resource (470 p.) |
| Disciplina | 615/.7924 |
| Soggetto topico |
Antiviral Agents -- therapeutic use
Antiviral agents Clinical Trials as Topic Drug Discovery Drug Evaluation Epidemiologic Studies Chemistry, Pharmaceutical Evaluation Studies as Topic Investigative Techniques Anti-Infective Agents Epidemiologic Methods Pharmacology Therapeutic Uses Health Care Evaluation Mechanisms Chemistry Biological Science Disciplines Natural Science Disciplines Quality of Health Care Public Health Pharmacologic Actions Environment and Public Health Health Care Quality, Access, and Evaluation Chemical Actions and Uses Health Care Antiviral Agents Health & Biological Sciences Pharmacy, Therapeutics, & Pharmacology |
| ISBN |
1-283-20363-4
9786613203632 0-470-92935-9 0-470-92934-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
ANTIVIRAL DRUGS; CONTENTS; CONTRIBUTORS; PREFACE; PART I HUMAN IMMUNODEFICIENCY VIRUS; 1 Discovery and Development of Atazanavir; 2 Discovery and Development of PL-100, A Novel HIV-1 Protease Inhibitor; 3 Darunavir (Prezista, TMC114): From Bench to Clinic, Improving Treatment Options for HIV-Infected Patients; 4 Discovery and Development of Tipranavir; 5 TMC278 (Rilpivirine): A Next-Generation NNRTI in Phase III Clinical Development for Treatment-Naive Patients; 6 Etravirine: From TMC125 to Intelence: A Treatment Paradigm Shift for HIV-Infected Patients
7 Discovery and Development of Tenofovir Disoproxil Fumarate8 Discovery and Development of Apricitabine; 9 Discovery and Development of Maraviroc and PF-232798: CCR5 Antagonists for the Treatment of HIV-1 Infection; 10 Discovery of the CCR5 Antagonist Vicriviroc (Sch 417690/Sch-D) for the Treatment of HIV-1 Infection; 11 Discovery and Development of HIV-1 Entry Inhibitors That Target gp120; 12 Discovery of MK-0536: A Potential Second-Generation HIV-1 Integrase Strand Transfer Inhibitor with a High Genetic Barrier to Mutation; 13 Discovery and Development of HIV Integrase Inhibitor Raltegravir 14 Elvitegravir: A Novel Monoketo Acid HIV-1 Integrase Strand Transfer InhibitorPART II HEPATITIS C VIRUS; 15 Discovery and Development of Telaprevir; 16 Discovery and Development of BILN 2061 and Follow-up BI 201335; 17 Intervention of Hepatitis C Replication Through NS3-4A, the Protease Inhibitor Boceprevir; 18 Discovery and Development of the HCV NS3/4A Protease Inhibitor Danoprevir (ITMN-191/RG7227); 19 Discovery and Development of the HCV Protease Inhibitor TMC435; 20 Discovery and Clinical Evaluation of the Nucleoside Analog Balapiravir (R1626) for the Treatment of HCV Infection 21 Discovery and Development of PSI-6130/RG712822 Discovery of Cyclophilin Inhibitor NIM811 as a Novel Therapeutic Agent for HCV; 23 HCV Viral Entry Inhibitors; PART III RESPIRATORY SYNCYTIAL VIRUS INHIBITORS; 24 Discovery of the RSV Inhibitor TMC353121; 25 Discovery and Development of Orally Active RSV Fusion Inhibitors; 26 Discovery and Development of RSV604; PART IV INFLUENZA, HEPATITIS B, AND CYTOMEGALOVIRUS INHIBITORS; 27 Discovery and Development of Influenza Virus Sialidase Inhibitor Relenza; 28 Discovery and Development of Entecavir 29 Benzimidazole Ribonucleosides: Novel Drug Candidates for the Prevention and Treatment of Cytomegalovirus DiseasesINDEX; Color Plate |
| Record Nr. | UNINA-9910808713803321 |
|
Kazmierski Wieslaw M
|
||
| Hoboken, : Wiley, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drug resistance updates
| Drug resistance updates |
| Pubbl/distr/stampa | [London], : Harcourt |
| Disciplina | 616 |
| Soggetto topico |
Drug resistance in microorganisms
Drug resistance in cancer cells Drug resistance Anti-infective agents Drug Resistance Antineoplastic Agents Anti-Infective Agents Communicable Diseases - drug therapy Neoplasms - drug therapy Résistance aux médicaments Micro-organismes - Résistance aux médicaments Cellules cancéreuses - Résistance aux médicaments Anticancéreux Antiinfectieux |
| Soggetto genere / forma |
Periodical
Periodicals. Périodiques. |
| ISSN | 1532-2084 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910333246203321 |
| [London], : Harcourt | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drug resistance updates
| Drug resistance updates |
| Pubbl/distr/stampa | [London], : Harcourt |
| Disciplina | 616 |
| Soggetto topico |
Drug resistance in microorganisms
Drug resistance in cancer cells Drug resistance Anti-infective agents Drug Resistance Antineoplastic Agents Anti-Infective Agents Communicable Diseases - drug therapy Neoplasms - drug therapy Résistance aux médicaments Micro-organismes - Résistance aux médicaments Cellules cancéreuses - Résistance aux médicaments Anticancéreux Antiinfectieux |
| Soggetto genere / forma |
Periodical
Periodicals. Périodiques. |
| ISSN | 1532-2084 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-996197983603316 |
| [London], : Harcourt | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Improving Access to HIV/AIDS Medicines in Africa [[electronic resource] ] : Assessment of Trade-related Aspects of Intellectual Property Rights (TRIPS) Flexibilities Utilization
| Improving Access to HIV/AIDS Medicines in Africa [[electronic resource] ] : Assessment of Trade-related Aspects of Intellectual Property Rights (TRIPS) Flexibilities Utilization |
| Autore | Osewe Patrick L (Patrick Lumumba) |
| Pubbl/distr/stampa | Washington, : World Bank Publications, 2008 |
| Descrizione fisica | 1 online resource (84 p.) |
| Disciplina | 362.196/9188061 |
| Collana | Directions in Development |
| Soggetto topico |
Antiretroviral agents
Antiretroviral agents - Africa, Sub-Saharan Delivery of Health Care Anti-Retroviral Agents Intellectual Property Industry Patient Care Management Antiviral Agents Technology, Industry, and Agriculture Jurisprudence Health Care Quality, Access, and Evaluation Social Control, Formal Health Services Administration Health Care Anti-Infective Agents Therapeutic Uses Health Care Economics and Organizations Sociology Pharmacologic Actions Social Sciences Chemical Actions and Uses Health Services Accessibility Drug Industry Anti-HIV Agents Patents as Topic Medicine Health & Biological Sciences Clinical Immunology |
| Soggetto genere / forma | Electronic books. |
| ISBN | 0-8213-7545-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Acknowledgments; Abbreviations and Acronyms; Overview; Chapter 1 Introduction; Chapter 2 Overview of the TRIPS Agreement and Flexibilities; Table 2.1 TRIPS Flexibilities That Facilitate Protection of Public Health; Chapter 3 Local Production: Experiences in Four African Countries; Table 3.1 Key Socioeconomic Indicators; Table 3.2 Varichem's ARV Production Line; Table 3.3 Cosmos's ARV Production Line; Table 3.4 Supply of ARVs to the South Africa Department of Health; Table 3.5 Danadams's ARV Production Line
Figure 3.1 Percentage of ARVs Purchased by Government of Ghana from Danadams and Other Firms 2005Figure 3.2 Comparison of Prices for Local and Imported Generic ARVs in Ghana, 2005; Chapter 4 Conclusions and Recommendations; Appendix A HIV/AIDS Medicines under Patent in Sub-Saharan Africa; Appendix B List of Persons Interviewed; Bibliography |
| Record Nr. | UNINA-9910453909703321 |
|
Osewe Patrick L (Patrick Lumumba)
|
||
| Washington, : World Bank Publications, 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Improving Access to HIV/AIDS Medicines in Africa [[electronic resource] ] : Assessment of Trade-related Aspects of Intellectual Property Rights (TRIPS) Flexibilities Utilization
| Improving Access to HIV/AIDS Medicines in Africa [[electronic resource] ] : Assessment of Trade-related Aspects of Intellectual Property Rights (TRIPS) Flexibilities Utilization |
| Autore | Osewe Patrick L (Patrick Lumumba) |
| Pubbl/distr/stampa | Washington, D.C., : World Bank Publications, 2008 |
| Descrizione fisica | 1 online resource (84 pages) |
| Disciplina | 362.196/9188061 |
| Collana | Directions in Development |
| Soggetto topico |
Antiretroviral agents
Antiretroviral agents - Africa, Sub-Saharan Delivery of Health Care Anti-Retroviral Agents Intellectual Property Industry Patient Care Management Antiviral Agents Technology, Industry, and Agriculture Jurisprudence Health Care Quality, Access, and Evaluation Social Control, Formal Health Services Administration Health Care Anti-Infective Agents Therapeutic Uses Health Care Economics and Organizations Sociology Pharmacologic Actions Social Sciences Chemical Actions and Uses Health Services Accessibility Drug Industry Anti-HIV Agents Patents as Topic |
| ISBN | 0-8213-7545-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Acknowledgments; Abbreviations and Acronyms; Overview; Chapter 1 Introduction; Chapter 2 Overview of the TRIPS Agreement and Flexibilities; Table 2.1 TRIPS Flexibilities That Facilitate Protection of Public Health; Chapter 3 Local Production: Experiences in Four African Countries; Table 3.1 Key Socioeconomic Indicators; Table 3.2 Varichem's ARV Production Line; Table 3.3 Cosmos's ARV Production Line; Table 3.4 Supply of ARVs to the South Africa Department of Health; Table 3.5 Danadams's ARV Production Line
Figure 3.1 Percentage of ARVs Purchased by Government of Ghana from Danadams and Other Firms 2005Figure 3.2 Comparison of Prices for Local and Imported Generic ARVs in Ghana, 2005; Chapter 4 Conclusions and Recommendations; Appendix A HIV/AIDS Medicines under Patent in Sub-Saharan Africa; Appendix B List of Persons Interviewed; Bibliography |
| Record Nr. | UNINA-9910782136403321 |
|
Osewe Patrick L (Patrick Lumumba)
|
||
| Washington, D.C., : World Bank Publications, 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Improving Access to HIV/AIDS Medicines in Africa [[electronic resource] ] : Assessment of Trade-related Aspects of Intellectual Property Rights (TRIPS) Flexibilities Utilization
| Improving Access to HIV/AIDS Medicines in Africa [[electronic resource] ] : Assessment of Trade-related Aspects of Intellectual Property Rights (TRIPS) Flexibilities Utilization |
| Autore | Osewe Patrick L (Patrick Lumumba) |
| Pubbl/distr/stampa | Washington, D.C., : World Bank Publications, 2008 |
| Descrizione fisica | 1 online resource (84 pages) |
| Disciplina | 362.196/9188061 |
| Collana | Directions in Development |
| Soggetto topico |
Antiretroviral agents
Antiretroviral agents - Africa, Sub-Saharan Delivery of Health Care Anti-Retroviral Agents Intellectual Property Industry Patient Care Management Antiviral Agents Technology, Industry, and Agriculture Jurisprudence Health Care Quality, Access, and Evaluation Social Control, Formal Health Services Administration Health Care Anti-Infective Agents Therapeutic Uses Health Care Economics and Organizations Sociology Pharmacologic Actions Social Sciences Chemical Actions and Uses Health Services Accessibility Drug Industry Anti-HIV Agents Patents as Topic |
| ISBN | 0-8213-7545-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Acknowledgments; Abbreviations and Acronyms; Overview; Chapter 1 Introduction; Chapter 2 Overview of the TRIPS Agreement and Flexibilities; Table 2.1 TRIPS Flexibilities That Facilitate Protection of Public Health; Chapter 3 Local Production: Experiences in Four African Countries; Table 3.1 Key Socioeconomic Indicators; Table 3.2 Varichem's ARV Production Line; Table 3.3 Cosmos's ARV Production Line; Table 3.4 Supply of ARVs to the South Africa Department of Health; Table 3.5 Danadams's ARV Production Line
Figure 3.1 Percentage of ARVs Purchased by Government of Ghana from Danadams and Other Firms 2005Figure 3.2 Comparison of Prices for Local and Imported Generic ARVs in Ghana, 2005; Chapter 4 Conclusions and Recommendations; Appendix A HIV/AIDS Medicines under Patent in Sub-Saharan Africa; Appendix B List of Persons Interviewed; Bibliography |
| Record Nr. | UNINA-9910815105703321 |
|
Osewe Patrick L (Patrick Lumumba)
|
||
| Washington, D.C., : World Bank Publications, 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
International journal of antimicrobial agents
| International journal of antimicrobial agents |
| Pubbl/distr/stampa | [Amsterdam?], : Elsevier Science |
| Disciplina | 616.905 |
| Soggetto topico |
Anti-infective agents
Anti-infective agents - Periodicals Anti-Bacterial Agents Anti-Infective Agents Antiinfectieux - Périodiques Antiinfectieux Antimikrobieller Wirkstoff Pharmakologie Zeitschrift Infektionskrankheit Pharmakotherapie |
| Soggetto genere / forma | Periodicals. |
| ISSN | 1872-7913 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-996212599803316 |
| [Amsterdam?], : Elsevier Science | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
